Dopamine transporter binding in females with panic disorder may vary with clinical status

Journal of Psychiatric Research

Volumn 44, Issue 1, 2010, Pages 56-59

  Maron, Eduard ^a,b   Nutt, David J ^b,c   Kuikka, Jyrki ^d   Tiihonen, Jari ^d  

^a UNIVERSITY OF TARTU   (Estonia)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

123I nor CIT; Dopamine transporter; Panic disorder; SPECT

Indexed keywords

DOPAMINE TRANSPORTER;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; PANIC; PRIORITY JOURNAL; PROTEIN BINDING; REMISSION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; ANALYSIS OF VARIANCE; BRAIN MAPPING; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; HUMANS; IODINE RADIOISOTOPES; MIDDLE AGED; ORGANOTECHNETIUM COMPOUNDS; PAIN MEASUREMENT; PANIC DISORDER; PROTEIN BINDING; PSYCHIATRIC STATUS RATING SCALES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; YOUNG ADULT;

EID: 72149114341     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2009.04.014     Document Type: Article

References (31)

1. Acton P.D., Kushner S.A., Kung M.P., Mozley P.D., Plössl K., and Kung H.F. Simplified reference region model for the kinetic analysis of [99mTc]TRODAT-1 binding to dopamine transporters in nonhuman primates using single-photon emission tomography. European Journal of Nuclear Medicine 26 (1999) 518-526
2. Bergström K.A., Halldin C., Hall H., Lundkvist C., Ginovart N., Swahn C.G., et al. In vitro and in vivo characterisation of nor-β-CIT: a potential radioligand for visualisation of the serotonin transporter in the brain. European Journal of Nuclear Medicine 24 (1997) 596-601
3. Brunswick D.J., Amsterdam J.D., Mozley P.D., and Newberg A. Greater availability of brain dopamine transporters in major depression shown by [99mTc]TRODAT-1 SPECT imaging. The American Journal of Psychiatry 160 (2003) 1836-1841
4. Clark D.M. A cognitive model of panic attacks. In: Rachman S., and Maser J.D. (Eds). Panic: psychological perspectives (1988), Lawrence Erlbaum, Hillsdale, NJ 71-90
5. Hesse S., Müller U., Lincke T., Barthel H., Villmann T., Angermeyer M.C., et al. Serotonin and dopamine transporter imaging in patients with obsessive-compulsive disorder. Psychiatry Research 140 (2005) 63-72
6. Hiltunen J., Akerman K.K., Kuikka J.T., Bergström K.A., Halldin C., Nikula T., et al. Iodine-123 labeled nor-β-CIT as a potential tracer for serotonin transporter imaging in the human brain with single-photon emission tomography. European Journal of Nuclear Medicine 25 (1998) 19-23
7. Kapur S. Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. The American Journal of Psychiatry 160 (2003) 13-23
8. 123I]IPT SPET in obsessive-compulsive disorder. European Journal of Nuclear Medicine and Molecular Imaging 30 (2003) 1637-1643
9. Kugaya A., Seneca N.M., Snyder P.J., Williams S.A., Malison R.T., Baldwin R.M., et al. Changes in human in vivo serotonin and dopamine transporter availabilities during chronic antidepressant administration. Neuropsychopharmacology 28 (2003) 413-420
10. Kuikka J.T., Tenhunen-Eskelinen M., Jurvelin J., and Kiiliänen H. Physical performance of the Siemens MultiSPECT 3 gamma camera. Nuclear Medicine Communications 14 (1993) 490-497
11. Laasonen-Balk T., Kuikka J., Viinamäki H., Husso-Saastamoinen M., Lehtonen J., and Tiihonen J. Striatal dopamine transporter density in major depression. Psychopharmacology (Berl) 144 (1999) 282-285
12. Lehto S.M., Tolmunen T., Kuikka J., Valkonen-Korhonen M., Joensuu M., Saarinen P.I., et al. Midbrain serotonin and striatum dopamine transporter binding in double depression: a one-year follow-up study. Neuroscience Letters 441 (2008) 291-295
13. Logan J., Fowler J.S., Volkow N.D., Wolf A.P., Dewey S.L., Schlyer D.J., et al. Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects. Journal of Cerebral Blood Flow & Metabolism 10 (1990) 740-747
14. Maron E., and Shlik J. Serotonin function in panic disorder: important, but why?. Neuropsychopharmacology 31 (2006) 1-11
15. Maron E., Kuikka J.T., Shlik J., Vasar V., Vanninen E., and Tiihonen J. Reduced brain serotonin transporter binding in patients with panic disorder. Psychiatry Research 132 (2004) 173-181
16. Meyer J.H., Krüger S., Wilson A.A., Christensen B.K., Goulding V.S., Schaffer A., et al. Lower dopamine transporter binding potential in striatum during depression. Neuroreport 12 (2001) 4121-4125
17. Nash J.R., Sargent P.A., Rabiner E.A., Hood S.D., Argyropoulos S.V., Potokar J.P., et al. Serotonin 5-HT1A receptor binding in people with panic disorder: positron emission tomography study. The British Journal of Psychiatry 193 (2008) 229-234
18. Neumeister A., Willeit M., Praschak-Rieder N., Asenbaum S., Stastny J., Hilger E., et al. Dopamine transporter availability in symptomatic depressed patients with seasonal affective disorder and healthy controls. Psychological Medicine 31 (2001) 1467-1473
19. Neumeister A., Bain E., Nugent A.C., Carson R.E., Bonne O., Luckenbaugh D.A., et al. Reduced serotonin type 1A receptor binding in panic disorder. The Journal of Neuroscience 24 (2004) 589-591
20. Pichot W., Hansenne M., Gonzalez Moreno A., and Ansseau M. Growth hormone response to apomorphine in panic disorder: comparison with major depression and normal controls. European Archives of Psychiatry and Clinical Neuroscience 245 (1995) 306-308
21. Pitchot W., Ansseau M., Gonzalez Moreno A., Hansenne M., and von Frenckell R. Dopaminergic function in panic disorder: comparison with major and minor depression. Biological Psychiatry 32 (1992) 1004-1011
22. Pogarell O., Poepperl G., Mulert C., Hamann C., Sadowsky N., Riedel M., et al. SERT and DAT availabilities under citalopram treatment in obsessive-compulsive disorder (OCD). European Neuropsychopharmacology 15 (2005) 521-524
23. Praschak-Rieder N., Willeit M., Wilson A.A., Houle S., and Meyer J.H. Seasonal variation in human brain serotonin transporter binding. Archives of General Psychiatry 65 (2008) 1072-1078
24. Sarchiapone M., Carli V., Camardese G., Cuomo C., Di Giuda D., Calcagni M.L., et al. Dopamine transporter binding in depressed patients with anhedonia. Psychiatry Research 147 (2006) 243-248
25. Simon N.M., Emmanuel N., Ballenger J., Worthington J.J., Kinrys G., Korbly N.B., et al. Bupropion sustained release for panic disorder. Psychopharmacology Bulletin 37 (2003) 66-72
26. Tiihonen J., Kuikka J., Bergström K., Lepola U., Koponen H., and Leinonen E. Dopamine reuptake site densities in patients with social phobia. The American Journal of Psychiatry 154 (1997) 239-242
27. 123I]{β}-CIT SPECT. The American Journal of Psychiatry 161 (2004) 2201-2206
28. 123I-β-(4-iodophenyl)-tropane SPECT. The Journal of Nuclear Medicine 49 (2008) 757-763
29. Weintraub D., Newberg A.B., Cary M.S., Siderowf A.D., Moberg P.J., Kleiner-Fisman G., et al. Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson's disease. The Journal of Nuclear Medicine 46 (2005) 227-232
30. Yang Y.K., Yeh T.L., Yao W.J., Lee I.H., Chen P.S., Chiu N.T., et al. Greater availability of dopamine transporters in patients with major depression - a dual-isotope SPECT study. Psychiatry Research 162 (2008) 230-235
31. Yoo H.K., Kim M.J., Kim S.J., Sung Y.H., Sim M.E., Lee Y.S., et al. Putaminal gray matter volume decrease in panic disorder: an optimized voxel-based morphometry study. European Journal of Neuroscience 22 (2005) 2089-2094